再冷冻对胚胎存活力和体外受精结局影响的系统评价与Meta分析
该系统评价与Meta分析检索了截至2022年10月10日的多个数据库,纳入14项比较研究,共4525个胚胎移植周期(单次冷冻对照组3270个,再冷冻实验组1255个)。结果显示,再冷冻与单次冷冻相比,活产率降低(OR 0.67,95%CI 0.50-0.90),流产率升高(OR 1.52,95%CI 1.16-1.98),新生儿结局无显著差异。作者认为再冷冻可导致胚胎存活力和IVF成功率下降,临床医生和胚胎学家应对再冷冻策略保持谨慎态度。
要点
- 再冷冻组活产率低于单次冷冻组(OR 0.67,95%CI 0.50-0.90)。
- 再冷冻组流产率高于单次冷冻组(OR 1.52,95%CI 1.16-1.98)。
- 慢速冷冻再冷冻的胚胎存活率(OR 0.51,95%CI 0.27-0.96)和临床妊娠率(OR 0.47,95%CI 0.23-0.96)降低。
核心结论
- 本Meta分析提示,与单次冷冻相比,再冷冻可导致胚胎存活力受损和IVF成功率降低,新生儿结局未受影响。
- 作者认为临床医生和胚胎学家应对再冷冻策略保持谨慎态度。
研究设计与样本
- 系统评价与Meta分析,检索PubMed、Embase、Cochrane Library和Scopus数据库至2022年10月10日。
- 纳入14项比较研究,共4525个胚胎移植周期(单次冷冻对照组3270个周期,再冷冻实验组1255个周期)。
- 采用随机效应和固定效应Meta分析模型合并OR及95%CI,并根据冷冻方法和冷冻或移植时机进行亚组分析。
主要发现
- 慢速冷冻再冷冻的胚胎存活率降低(OR 0.51,95%CI 0.27-0.96),临床妊娠率降低(OR 0.47,95%CI 0.23-0.96)。
- 玻璃化再冷冻胚胎的活产率明显受影响(OR 0.60,95%CI 0.38-0.94)。
- 总体再冷冻组活产率低于单次冷冻组(OR 0.67,95%CI 0.50-0.90),流产率高于单次冷冻组(OR 1.52,95%CI 1.16-1.98)。
- 新生儿结局无显著差异。
- 囊胚期冷冻和移植时,再冷冻组与单次冷冻组的胚胎种植率(OR 0.59,95%CI 0.39-0.89)和活产率(OR 0.60,95%CI 0.37-0.96)有显著差异。
临床怎么用
- 作者认为临床医生和胚胎学家应对再冷冻策略保持谨慎态度。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To investigate the impact of recryopreservation on embryo viability and the outcomes of in vitro fertilization (IVF) by comparison with single cryopreservation. There is a lack of consensus and reliable evidence regarding the impact of recryopreservation techniques on human embryos, particularly with respect to embryo viability and IVF outcomes. DESIGN: Systematic review and meta-analysis. SETTING: Not applicable. INTERVENTION(S): Various databases such as PubMed, Embase, Cochrane Library, and Scopus were searched until October 10, 2022. All comparative studies comparing embryonic and IVF outcomes between repeated and single cryopreservation of embryos were included. The random-effect and fixed-effect meta-analysis models were used to pool the odds ratio (OR) and corresponding 95% confidence intervals (CIs). A subgroup analysis was performed based on different methods of cryopreservation and different times of embryo cryopreservation or transfer. MAIN OUTCOME MEASURE(S): Outcomes referring to embryo surviva l, IVF outcomes (including clinical pregnancy rate, embryo implantation rate, miscarriage rate, and live birth rate), and neonatal outcomes (including low birth weight rate and preterm birth rate) were evaluated. RESULT(S): Fourteen studies were eligible for the present meta-analysis, involving 4,525 embryo transfer cycles in total (3,270 cycles with single cryopreservation [control group] and 1,255 with recryopreservation [experimental group]). Decreased embryo survival (OR, 0.51; 95% CI, 0.27-0.96) and clinical pregnancy rates (OR, 0.47; 95% CI, 0.23-0.96) were found in embryos that were recryopreserved by slow freezing. The live birth rate of revitrified embryos was also notably affected (OR, 0.60; 95% CI, 0.38-0.94). Overall, recryopreservation resulted in a decreased live birth rate (OR, 0.67; 95% CI, 0.50-0.90) and an increased miscarriage rate (OR, 1.52; 95% CI, 1.16-1.98) compared with single cryopreservation. No significant difference was found in neonatal outcomes. When embryos were cryopreserved and transferred at the blastocyst stage, both the embryo implantation rate (OR, 0.59; 95% CI, 0.39-0.89) and live birth rate (OR, 0.60; 95% CI, 0.37-0.96) were significantly different between the 2 groups. CONCLUSION(S): The present meta-analysis suggested that recryopreservation, compared with single cryopreservation, can lead to impaired embryo viability and a lower rate of IVF success, with no affected neonatal outcomes. Clinicians and embryologists should retain a cautious attitude toward recryopreservation strategies. REGISTRATION NUMBER: CRD42022359456.
引用
- Wang X, Mao R, Wang M, et al. The effect of recryopreservation on embryo viability and outcomes of in vitro fertilization: a systematic review and meta-analysis. Fertil Steril. 2023. PMID: 36940738. doi:10.1016/j.fertnstert.2023.03.001
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。